2013·Masters·University of Zambia
BACKGOUND: There is increasing evidence that the current clinical and immunological monitoring tools are not sufficient to identify early enough patients who are failing on treatment. Development of resistance to the limited treatment options for children and premature switching are the dangers....
Download PDF ↓